The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status

Thorax

Volumn 68, Issue 1, 2013, Pages 57-65

  Patel, Amit Suresh ^a   Siegert, Richard J ^b   Creamer, Daniel ^c   Larkin, Genevieve ^c   Maher, Toby M ^d   Renzoni, Elisabetta A ^d   Wells, Athol U ^d   Higginson, Irene J ^a   Birring, Surinder S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; DISEASE EXACERBATION; DRUG EFFECT; ETHNICITY; EYE DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; KING SARCOIDOSIS QUESTIONNAIRE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCIBILITY; SEX DIFFERENCE; SKIN DISEASE; SMOKING HABIT; VALIDATION PROCESS;

EID: 84871379788     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201962     Document Type: Article

References (26)

1. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
2. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-9. (Pubitemid 33152325)
3. Michielsen HJ, Peros-Golubicic T, Drent M, et al. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007;74:401-5. (Pubitemid 47093152)
4. Michielsen HJ, Drent M, Peros-Golubicic T, et al. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006;130:989-94. (Pubitemid 44583726)
5. Chang B, Steimel J, Moller DR, et al. Depression in sarcoidosis. Am J Respir Crit Care Med 2001;163:329-34. (Pubitemid 32158507)
6. Wasfi YS, Rose CS, Murphy JR, et al. A new tool to assess sarcoidosis severity. Chest 2006;129:1234-45.
7. De Vries J, Drent M. Quality of life and health status in interstitial lung diseases. Curr Opin Pulm Med 2006;12:354-8. (Pubitemid 44315781)
8. Drent M, Wirnsberger RM, Breteler MH, et al. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:59-66. (Pubitemid 28174898)
9. Cox CE, Donohue JF, Brown CD, et al. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med 2003;168:323-9. (Pubitemid 36969884)
10. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:75-86. (Pubitemid 29164274)
11. Birring SS, Prudon B, Carr AJ, et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58:339-43. (Pubitemid 36411421)
12. Rasch G. Probabilistic Models for Some Intelligence and Attainment Tests. Chicago, Illinois: University of Chicago Press, 1960.
13. Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax 2010;65:921-6.
14. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007;57:1358-62. (Pubitemid 350308830)
15. Michielsen HJ, De VJ, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scale. J Psychosom Res 2003;54:345-52. (Pubitemid 38365998)
16. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4.
17. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
18. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
19. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-16. (Pubitemid 24194579)
20. Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 2004;51:563-9. (Pubitemid 39278075)
21. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-8. (Pubitemid 32652197)
22. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34-42. (Pubitemid 44856236)
23. Swigris JJ, Wilson SR, Green KE, et al. Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes 2010;8:77.
24. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001;56:880-7. (Pubitemid 32999838)
25. Bourbonnais JM, Samavati L. Effect of gender on health related quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2010;27:96-102.
26. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.